Profile
Stephen Franklin is the founder of three companies.
Evgen Pharma Plc was founded in 2007, where he held the title of Chief Executive Officer & Director from 2014 to 2020.
Provexis Plc was founded in 2002, where he held the title of Chief Executive Officer from 2002 to 2007.
Evgen Ltd.
was founded in 2008, where he held the title of Director from 2008 to 2020.
Dr. Franklin's former jobs include being a Principal Executive at ANGLE Plc from 1998 to 2002 and a Manager-Business Development at Manchester Biotech Ltd.
Dr. Franklin received his undergraduate degree from York University in 1989, his MBA from The University of Nottingham in 1999, and his doctorate from The University of Nottingham in 1993.
Former positions of Stephen Franklin
| Companies | Position | End |
|---|---|---|
Evgen Ltd.
 Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Founder | 30/04/2020 |
| THERACRYF PLC | Founder | 30/04/2020 |
| PROVEXIS PLC | Chief Executive Officer | 01/07/2007 |
| ANGLE PLC | Corporate Officer/Principal | 01/09/2002 |
| Manchester Biotech Ltd. | Corporate Officer/Principal | - |
Training of Stephen Franklin
| The University of Nottingham | Masters Business Admin |
| York University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PROVEXIS PLC | Health Technology |
| ANGLE PLC | Distribution Services |
| THERACRYF PLC | Health Services |
| Private companies | 2 |
|---|---|
Evgen Ltd.
Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
| Manchester Biotech Ltd. |
- Stock Market
- Insiders
- Stephen Franklin
